Back to Authors

Walton, Monica P.

Mayo Clinic

Oregon Health & Science University

Citations 2

Music Therapy Intervention to Reduce Symptom Burden in Hospice Patients: A Descriptive Study
Estell, Madison, Whitford, Kevin J. , Ulrich, Angela M., Larsen, Brianna E. , Wood, Christina M., Bigelow, Maureen L., Dockter, Travis , Schoonover, Kimberly , Stelpflug, Amy J., Strand, Jacob J. , Walton, Monica P., Estell, Madison H, Wood, Christina, Dockter, Travis J, Schoonover, Kimberly L, Lapid, Maria I.

American Journal of Hospice and Palliative Medicine® | March 19, 2024 | Volume: 42 | Issue: 1 | Pages: 102-111

10.1177/10499091241237991 Get It

Background: Music therapy (MT) offers benefits of improved symptom relief and quality of life at the end of life, but its impact on hospice patients and caregivers needs more research. Objective: To assess the impact of MT intervention on symptom burden and well-being of hospice patients and caregivers. Methods: A total of 18 hospice patients, selected based on scores ≥4 on the revised Edmonton Symptom Assessment System (ESAS-r) items on pain, depression, anxiety, or well-being, participated in MT sessions provided by a board-certified music therapist. Over a period of 2-3 weeks, 3-4 MT sessions were conducted for each. Patient Quality of life (QOL) was assessed using the Linear Analogue Self-Assessment (LASA). Depression and anxiety were measured with the Patient Health Questionnaire-4 (PHQ-4). For the 7 caregivers enrolled, stress levels were measured using the Pearlin role overload measure and LASA. Results: Patients reported a reduction in symptom severity and emotional distress and an increase in QOL. All patients endorsed satisfaction with music therapy, describing it as particularly beneficial for stress relief, relaxation, spiritual support, emotional support, and well-being. Scores on overall QOL and stress were worse for caregivers. Conclusion: This study provides evidence that MT reduces symptom burden and enhances the quality of life for hospice patients. Hospice patients and their caregivers endorsed satisfaction with MT. Given the benefits observed, integrating MT into hospice care regimens could potentially improve patient and caregiver outcomes. Larger studies should be conducted to better assess the impact of MT in this population.
Impact of Massage Therapy on the Quality of Life of Hospice Patients and Their Caregivers: A Pilot Study
Havyer, Rachel D. , Dockter, Travis , McCue, Shaylene , Stelpflug, Amy J., Bigelow, Maureen L., Robsahm, Mary Meg, Elwood, Theresa, Strand, Jacob J. , Bauer, Brent A. , Cutshall, Susanne M. , Sloan, Jeff A. , Walton, Monica P., Whitford, Kevin J. , Dockter, Travis J, Lapid, Maria I.

Journal of Palliative Care | November 20, 2020 | Volume: 37 | Issue: 1 | Pages: 41-47

10.1177/0825859720975991 Get It

Evidence for massage therapy (MT) in hospice patients remains limited. We conducted a prospective pilot study on MTs impact on quality of life of hospice patients and caregivers. Patient-caregiver dyads were enrolled if patients scored ≥5 on pain, depression, anxiety, or well-being using the revised Edmonton Symptom Assessment System Revised (ESAS-r). The patient received MT weekly for up to 3 massages with assessments completed at baseline, after each massage, and 1 week after the final massage for patients and at baseline and 1 week after final massage for caregivers. A satisfaction survey was completed at study completion. A pro-rated area under the curve (AUC) was utilized to assess the primary endpoints of change in ESAS-r for patient ratings of pain, depression and anxiety as well as the Linear Analogue Self-Assessment (LASA). Median difference scores (end of study value)-(baseline value) for each participant and caregiver were calculated. Of 27 patients and caregivers enrolled, 25 patients received MT. Fifteen patients completed all 3 MT sessions and were given the final symptom assessment and satisfaction survey and their caregivers completed final assessments. The proportion of patients considered success (AUC > baseline) in the primary endpoints were the following: pain 40.9%, depression 40.9%, anxiety 54.5%, LASA 54.5%. Median difference scores were largely zero indicating no significant temporal change in symptoms. Patients were highly satisfied with MT. This pilot study indicated that MT was a feasible and well-received intervention in our population of patients with inadequately controlled symptoms.